|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clevers H and Nusse R: Wnt/beta-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Behrens J, Jerchow BA, Würtele M, Grimm J,
Asbrand C, Wirtz R, Kühl M, Wedlich D and Birchmeier W: Functional
interaction of an axin homolog, conductin, with beta-catenin, APC,
and GSK3beta. Science. 280:596–599. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ikeda S, Kishida S, Yamamoto H, Murai H,
Koyama S and Kikuchi A: Axin, a negative regulator of the Wnt
signaling pathway, forms a complex with GSK-3beta and beta-catenin
and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
EMBO J. 17:1371–1384. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ogasawara N, Tsukamoto T, Mizoshita T,
Inada K, Cao X, Takenaka Y, Joh T and Tatematsu M: Mutations and
nuclear accumulation of beta-catenin correlate with intestinal
phenotypic expression in human gastric cancer. Histopathology.
49:612–621. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klaus A and Birchmeier W: Wnt signaling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clevers H: Wnt/β-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu W, Dong X, Mai M, Seelan RS, Taniquchi
K, Krishnadath KK, Halling KC, Cunningham JM, Boardman LA, Qian C,
Christensen E, Schmidt SS, Roche PC, Smith DI and Thibodeau SN:
Mutations in AXIN2 cause colorectal cancer with defective mismatch
repair by activating beta-catenin/TCF signaling. Nat Genet.
26:5012000. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hatakeyama S: TRIM proteins and cancer.
Nat Rev Cancer. 11:792–804. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herquel B, Ouararhni K and Davidson I: The
TIF1α-related TRIM cofactors couple chromatin modifications to
transcriptional regulation, signaling and tumor suppression.
Transcription. 2:231–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Allton K, Jain AK, Herz HM, Tsai WW, Jung
SY, Qin J, Bergmann A, Johnson RL and Barton MC: Trim24 targets
endogenous p53 for degradation. Proc Natl Acad Sci USA.
106:11612–11616. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jain AK and Barton MC: Regulation of p53:
TRIM24 enters the RING. Cell Cycle. 8:3668–3674. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tsai WW, Wang Z, Yiu TT, Tsai WW, Jung SY,
Qin J, Bergmann A, Johnson RL, Barton MC, Aronow B, et al: TRIM24
links a non-canonical histone signature to breast cancer. Nature.
468:927–932. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pathiraja TN, Thakkar KN, Jiang S,
Stratton S, Liu Z, Gagea M, Shi X, Shah PK, Phan L, Lee MH, et al:
TRIM24 links glucose metabolism with transformation of human
mammary epithelial cells. Oncogene. 34:2836–2845. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhong S, Delva L, Rachez C, Cenciarelli C,
Gandini D, Zhang H, Kalantry S, Freedman LP, Pandolfi PP, et al: A
RA-dependent, tumour-growth suppressive transcription complex is
the target of the PML-RARalpha and T18 oncoproteins. Nat Genet.
23:287–295. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Belloni E, Trubia M, Gasparini P, Micucci
C, Tapinassi C, Confalonieri S, Nuciforo P, Martino B, Lo-Coco F,
Pelicci PG and Di Fiore PP: 8p11 myeloproliferative syndrome with a
novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1
genes. Genes Chromosomes Cancer. 42:320–325. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Klugbauer S and Rabes HM: The
transcription coactivator HTIF1 and a related protein are fused to
the RET receptor tyrosine kinase in childhood papillary thyroid
carcinomas. Oncogene. 18:4388–4393. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Heidt DG, Lee CJ, Yang H, Logsdon
CD, Zhang L, Fearon ER, Ljungman M and Simeone DM: Oncogenic
function of ATDC in pancreatic cancer through Wnt pathway
activation and beta-catenin stabilization. Cancer Cell. 15:207–219.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Huang Y, Yang D, Li X, Liang J, Lin
L, Zhang M, Zhong K, Liang B and Li J: Overexpression of TRIM24 is
associated with the onset and progress of human hepatocellular
carcinoma. PloS One. 9:e854622014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. Springer; New
York, NY: 2010
|
|
21
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the Digestive System.
4th. IARC Press; Lyon: 2010
|
|
22
|
Pan X, Zhou T, Tai YH, Wang C, Zhao J, Cao
Y, Chen Y, Zhang PJ, Yu M, Zhen C, et al: Elevated expression of
CUEDC2 protein confers endocrine resistance in breast cancer. Nat
Med. 17:708–714. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J
and Sung JJ: Dysregulation of cellular signaling in gastric cancer.
Cancer Lett. 295:144–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chambon M, Orsetti B, Berthe ML,
Bascoul-Mollevi C, Rodriguez C, Duong V, Gleizes M, Thénot S,
Bibeau F, Theillet C and Cavaillès V: Prognostic significance of
TRIM24/TIF-1α gene expression in breast cancer. Am J Pathol.
178:1461–1469. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cui Z, Cao W, Li J, Song X, Mao L and Chen
W: TRIM24 overexpression is common in locally advanced head and
neck squamous cell carcinoma and correlates with aggressive
malignant phenotypes. PloS One. 8:e638872013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang LH, Yin AA, Cheng JX, Huang HY, Li
XM, Zhang YQ, Han N and Zhang X: TRIM24 promotes glioma progression
and enhances chemoresistance through activation of the PI3K/Akt
signaling pathway. Oncogene. 34:600–610. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li H, Sun L, Tang Z, Fu L, Xu Y, Li Z, Luo
W, Qiu X and Wang E: Overexpression of TRIM24 correlates with tumor
progression in non-small cell lung cancer. PloS One. 7:e376572012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xue D, Zhang X, Liu J, Liu J, Li N, Liu C,
Liu Y and Wang P: Clinical significance and biological roles of
TRIM24 in human bladder carcinoma. Tumour Biol. 36:6849–6855. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang J, Zhu J, Dong M, Yu H, Dai X and Li
K: Knockdown of tripartite motif containing 24 by lentivirus
suppresses cell growth and induces apoptosis in human colorectal
cancer cells. Oncol Res. 22:39–45. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jain AK, Allton K, Duncan AD and Barton
MC: TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes
ATM-mediated phosphorylation and autodegradation during DNA damage.
Mol Cell Biol. 34:2695–2709. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Knudsen KE, Diehl JA, Haiman CA and
Knudsen ES: Cyclin D1: Polymorphism, aberrant splicing and cancer
risk. Oncogene. 25:1620–1628. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roy PG and Thompson AM: Cyclin D1 and
breast cancer. Breast. 15:718–727. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kishimoto I, Mitomi H, Ohkura Y, Kanazawa
H, Fukui N and Watanabe M: Abnormal expression of p16 (INK4a),
cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in
gastric carcinomas. J Surg Oncol. 98:60–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Niu Z, Liu H, Zhou M, Wang H, Liu Y, Li X,
Xiong W, Ma J, Li X and Li G: Knockdown of c-Myc inhibits cell
proliferation by negatively regulating the Cdk/Rb/E2F pathway in
nasopharyngeal carcinoma cells. Acta Biochim Biophys Sin
(Shanghai). 47:183–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Howard S, Deroo T, Fujita Y and Itasaki N:
A positive role of cadherin in Wnt/β-catenin signalling during
epithelial-mesenchymal transition. PloS One. 6:e238992011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Polette M, Mestdagt M, Bindels S,
Nawrocki-Raby B, Hunziker W, Foidart JM, Birembaut P and Gilles C:
Beta-catenin and ZO-1: Shuttle molecules involved in tumor
invasion-associated epithelial-mesenchymal transition processes.
Cells Tissues Organs. 185:61–65. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Valenta T, Hausmann G and Basler K: The
many faces and functions of β-catenin. EMBO J. 31:2714–2736. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Miyazawa K, Iwaya K, Kuroda M, Harada M,
Serizawa H, Koyanagi Y, Sato Y, Mizokami Y, Matsuoka T and Mukai K:
Nuclear accumulation of beta-catenin in intestinal-type gastric
carcinoma: Correlation with early tumor invasion. Virchows Arch.
437:508–513. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chiu CG, Chan SK, Fang ZA, Masoudi H,
Wood-Baker R, Jones SJ, Gilks B, Laskin J and Wiseman SM:
Beta-catenin expression is prognostic of improved non-small cell
lung cancer survival. Am J Surg. 203:654–659. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miao ZF, Wang ZN, Zhao TT, Xu YY, Wu JH,
Liu XY, Xu H, You Y and Xu HM: TRIM24 is upregulated in human
gastric cancer and promotes gastric cancer cell growth and
chemoresistance. Virchows Arch. 466:525–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ying Y and Tao Q: Epigenetic disruption of
the WNT/beta-catenin signaling pathway in human cancers.
Epigenetics. 4:307–312. 2009. View Article : Google Scholar
|
|
46
|
Liu Y, Huang T, Zhao X and Cheng L:
MicroRNAs modulate the Wnt signaling pathway through targeting its
inhibitors. Biochem Biophys Res Commun. 408:259–264. 2011.
View Article : Google Scholar : PubMed/NCBI
|
